Study
Sequencing of serial plasma and multiregional tumor samples in a patient with metastatic breast cancer
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001001466 | Other |
Study Description
Circulating tumor DNA analysis can be used to track tumor burden and analyze cancer genomes non-invasively but the extent to which it represents metastatic heterogeneity is unknown. Here, we follow a patient with metastatic ER and HER2 positive breast cancer receiving two lines of targeted therapy over 3 years. We characterize genomic architecture and infer clonal evolution in 8 tumor biopsies and 9 plasma samples collected over 1,193 days of clinical follow-up using exome and targeted amplicon sequencing.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001002108 |
Exome and targeted amplicon sequencing data for tumor, germline and plasma samples from a patient with metastatic breast cancer.
|
Illumina HiSeq 2500,Illumina MiSeq | 30 |
Who archives the data?
Publications
Citations
Retrieving...
Retrieving...
